In a session titled 'Will mRNA lead to a long-awaited HIV vaccine?' co-chaired by Susan Buchbinder, US, and Georgia Tomaras, US, experts discussed the similarities and differences between HIV and SARS-CoV-2 mRNA vaccine development and how the renewed interest in exploiting the technology for the former—owing to its success in combatting...